<DOC>
	<DOCNO>NCT01258439</DOCNO>
	<brief_summary>This research study effect three drug use treat HIV infection . Some drug use treat HIV associate change blood fat cholesterol could harmful long-term , blood fat change associate small , increased risk heart disease stroke study adult HIV . Now HIV control long period patient , heart disease one big cause illness death general population , important develop new HIV treatment control HIV effectively cause abnormal blood fat . Hypothesis : That Raltegravir result less post-prandial lipid disturbance ritonavir-boosted darunavir .</brief_summary>
	<brief_title>Post-prandial Lipid Effects Raltegravir ( RAL ) v Ritonavir -Boosted Darunavir ( DRV-r ) Anti-retroviral Therapy ( ART ) - Naive Adults Adults Recommencing ART .</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Darunavir</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<mesh_term>Emtricitabine , Tenofovir Disoproxil Fumarate Drug Combination</mesh_term>
	<mesh_term>Emtricitabine</mesh_term>
	<mesh_term>Raltegravir Potassium</mesh_term>
	<criteria>Provision sign , inform consent Age &gt; 18 year HIV infection document HIV antibody test Western Blot prior study entry No previous ART OR ART 6 month prior randomisation CD4+ count &lt; 500 cells/mm viral load &gt; 10,000 copies/ml within 60 day prior randomisation No genotypic resistance Raltegravir , Tenofovir/emtricitabine , Darunavir , Ritonavir Body mass index less 30kg/m2 Primary HIV infection within last 6 month Active infection opportunistic illness within previous 30 day Use medication contraindicate ritonavirboosted darunavir raltegravir Use lipidlowering therapy Diabetes mellitus ( fast glucose &gt; 7.0mml/l prior diagnosis diabetes ) Use oral prednisolone &gt; 7.5mg daily equivalent pregnancy Breast feeding proven hypersensitivity one component study meal</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>HIV</keyword>
	<keyword>cardiovascular disease</keyword>
	<keyword>post prandial lipid</keyword>
	<keyword>ritonavir</keyword>
	<keyword>darunavir</keyword>
	<keyword>raltegravir</keyword>
	<keyword>arterial stiffness</keyword>
	<keyword>tonometry</keyword>
</DOC>